Create a free account to keep browsing
It takes 30 seconds. You can open three notice pages a day without an account; a free account opens every notice, and lists the ones in your NAICS codes.
RFI Lupus Research Program (LRP) Public
Defense Health Agency · DEFENSE HEALTH AGENCY
Respond by: Nov 16, 2026, 4:00 PM UTC−517 days left
From SAM.gov's public data file generated Oct 29, 2026, 3:30 AM UTC; newest notice posted Oct 29, 2026; loaded into FedSub Oct 29, 2026, 5:46 AM UTC
Notice facts
Source: SAM.gov Contract Opportunities public data file
- Solicitation number
- HT9427RFI2027LRP
- Notice type
- Sources sought
- Posted
- Oct 14, 2026 · Amended Oct 15, 2026
- Response date
- Respond by Nov 16, 2026, 4:00 PM UTC−5
- Set-aside
- None stated
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Frederick, MD 21702
- Contracting office
- DEFENSE HEALTH AGENCY (HT9427)FORT DETRICK, MD 21702
- Agency
- Department of Defense · Defense Health Agency
Past prime awardees
Source: Award history, not a list of bidders on this notice
Past prime awardees · award history, not a list of bidders on this notice
12 companies held prime contracts from this office under NAICS 541714; 2 of them reported first-tier subawards to companies with NAICS 541714 in FedSub's records.
- LEIDOS, INC. · Reported first-tier subawards to 50 companies with NAICS 541714 in FedSub's records (latest Jun 2026).
11 more past prime awardees on Professional
Description
Source: SAM.gov Contract Opportunities public data file
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform potential future Lupus Research Program (LRP) focus areas and associated research funding opportunities. Although fiscal year 2027 (FY27) funds have not been appropriated, the LRP is requesting this information to support program planning processes. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI is for information and planning purposes only and should not be construed as a solicitation or an obligation on the part of the LRP or the Department of War. BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP LRP’s vision is to cure lupus through partnership of scientists, clinicians and persons affected by lupus. The LRP’s mission is to fund research to understand, prevent, and diagnose lupus and to improve treatments and quality of life of patients, including Service Members and their Families, Veterans and the general public. Appropriations for the LRP from FY17-24 and FY26 totaled $75 million. As of October 2026, FY27 funds for the LRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the LRP. Additional information about the LRP can be found here: https://cdmrp.health.mil/lrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-LRP-RFI
Versions on SAM.gov
Source: SAM.gov Contract Opportunities public data file
Posted Oct 15, 2026Sources soughtCurrent version
Respond by Nov 16, 2026, 4:00 PM UTC−5
Changed from the version before: Description
This version on SAM.gov (opens SAM.gov in a new tab)Posted Oct 14, 2026Sources sought
Respond by Nov 16, 2026, 4:00 PM UTC−5
This version on SAM.gov (opens SAM.gov in a new tab)